以细胞外囊泡为基础的治疗药物向大脑
Anastasia Williams1, Heather Branscome1,2, Fatah Kashanchi1
1Laboratory of Molecular Virology, School of Systems Biology, George Mason University, Discovery Hall Room 248, 10900 University Blvd, Manassas, VA 20110, USA.
Cells
|April 11, 2025
概括
细胞外囊泡 (EVs) 显示出通过血脑屏障 (BBB) 传递药物的潜力,以治疗中枢神经系统疾病. 本综述详细介绍了脑向策略和基于电动汽车的治疗方法的未来前景.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 神经科学是一个神经科学.
背景情况:
- 细胞外囊泡 (EVs) 是天然的纳米粒子,具有药物输送潜力.
- 电动汽车可以克服生理障碍,包括血脑屏障 (BBB).
- 这种能力对于治疗中枢神经系统 (CNS) 疾病至关重要.
研究的目的:
- 审查使用电动汽车成功针对大脑的因素和技术.
- 探索增强EV向大脑输送的策略.
- 讨论基于电动汽车的脑疗法的挑战和未来方向.
主要方法:
- 对EV交付的管理路径的审查.
- 对EV生物起源进行分析以确定目标.
- 使用连接剂对EV表面修饰的讨论.
- 检查大规模的电动汽车生产和药物装载.
主要成果:
- 电动汽车为穿越BBB提供了一个可行的平台.
- 存在各种策略来增强EV大脑准.
- 在可扩展的生产和高效的药物装载方面仍然存在挑战.
结论:
- 由于其BBB穿越能力,电动汽车对中枢神经系统的药物输送充满希望.
- 优化管理路径,EV源和表面修改是关键.
- 解决生产和加载挑战将推动脑输送的EV疗法.
相关概念视频
Drug Delivery: Parenteral Route
333
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
333
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
190
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
190


